COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,010 Articles (22,627 medRxiv, 8,383 bioRxiv)

Most recent first Previous |  Page 2171: Articles 21701-21710  | Next

Safety and efficacy of pharmacotherapy used for the management of COVID 19: A systematic review and meta-analysis of randomized control trials
Sah, S. K., Undela, K., Chand, D. S., Ramesh, M., R, S., Gona, O. J., George, S. M., UP, N., Aryal, S., P, N., Shastry, C. S.
10.1101/2020.10.02.20206045 — Posted: 2020-10-05
Impact of pathogen reduction technologies on immunological propertiesof the COVID-19 convalescent plasma
Kostin, A. I., Lundgren, M. N., Bulanov, A. Y., Ladygina, E. A., Chirkova, K., Gintsburg, A., Logunov, D., Dolzhikova, I., Shcheblyakov, D., Borovkova, N. V., Godkov, M. A., Bazhenov, A. I., Shustov, V., Bogdanova, A., Kamalova, A., Ganchin, V., Dombrovskiy, E., Volkov, S., Drozdova, N. E., Petrikov, S. S.
10.1101/2020.10.02.20205567 — Posted: 2020-10-05
Evaluating the Efficacy of COVID-19 Vaccines
Lin, D.-Y., Zeng, D., Mehrotra, D. V., Corey, L., Gilbert, P. B.
10.1101/2020.10.02.20205906 — Posted: 2020-10-05
Early transfusion of a large cohort of COVID-19 patients with high titer anti-SARS-CoV-2 spike protein IgG convalescent plasma confirms a signal of significantly decreased mortality
Salazar, E., Christensen, P. A., Graviss, E. A., Ngyuen, D. T., Castillo, B., Chen, J., Valdez Lopez, B., Eager, T., Yi, X., Zhao, P., Rogers, J., Shehabeldin, A., Joseph, D., Masud, F., Leveque, C., Olsen, R. J., Bernard, D. W., Gollihar, J., Musser, J. M.
10.1101/2020.10.02.20206029 — Posted: 2020-10-05
COVID-19 severity in asthma patients: A multi-center matched cohort study
Robinson, L. B., Wang, L., Fu, X., Wallace, Z. S., Long, A. A., Zhang, Y., Camargo, C. A., Blumenthal, K. G.
10.1101/2020.10.02.20205724 — Posted: 2020-10-05 Discussion: Offsite
Validation of self-collected buccal swab and saliva as a diagnostic tool for COVID-19
Ku, C. W., Durai, S., Kwan, J. Q. T., Loy, S. L., Erwin, C., Ko, K. K. K., Ng, X. W., Oon, L., Thoon, K. C., Kalimuddin, S., Chan, J. K.
10.1101/2020.10.03.20205278 — Posted: 2020-10-05
Reference ontology and database annotation of the COVID-19 Open Research Dataset (CORD-19)
Giles, O., Huntley, R., Karlsson, A., Lomax, J., Malone, J.
10.1101/2020.10.04.325266 — Posted: 2020-10-05
A national study of self-reported COVID symptoms during the first viral wave in Canada
Tang, X., Gelband, H., Lam, T., Nagelkerke, N., Reid, A., Jha, P., Action to beat Coronavirus (Ab-C) Study Investigators
10.1101/2020.10.02.20205930 — Posted: 2020-10-05
In vitro efficacy of Artemisinin-based treatments against SARS-CoV-2
Gilmore, K., Zhou, Y., Ramirez, S., Pham, L. V., Fahnoe, U., Feng, S., Offersgaard, A., Trimpert, J., Bukh, J., Osterrieder, K., Gottwein, J., Seeberger, P. H.
10.1101/2020.10.05.326637 — Posted: 2020-10-05
Metabolic syndrome increases COVID-19-related mortality in the UK Biobank sample
Morys, F., Dagher, A.
10.1101/2020.10.02.20205716 — Posted: 2020-10-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).